The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

2015/02/09 by Luping Lin, Amit J Sabnis, Amit J. Sabnis +48 · 3 citations
Biochemistry, Genetics and Molecular Biology · #Hippo pathway signaling and YAP/TAZ #Melanoma and MAPK Pathways

paper · doi:10.1038/ng.3218

openalex publication_date 2015/02/09 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Cited by

• The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
• Acquired resistance in cancer: towards targeted therapeutic strategies
• Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches